WHO issues guidelines for contested breast implants

The World Health Organisation (WHO) on Tuesday intervened for the first time in the roiling global scandal over faulty breast implants, urging women with the devices to seek medical advice if they have any concerns.

"Persons with PIP or M-Implant prostheses should consult their doctor or surgeon if they suspect rupture, have pain or inflammation or any other concerns," UN's health agency said, referring to the brands implicated in the controversy.

"Affected persons and physicians should take note of their authority recommendations and act accordingly," it said in a "Global Alert and Response" statement issued on its website.

Around 300,000 women in 65 countries are believed to have received implants made by Poly Implant Prothese (PIP), a now-defunct manufacturer in southern France, although some figures are much higher.

France, Germany and the Czech Republic have recommended that the devices be removed as a precaution but Britain has said it will not follow suit.

The prostheses were withdrawn from the European market in 2010 after France's health watchdog discovered they were made from sub-standard, industrial-grade gel.

The WHO said data about from the implants was sketchy and hoped for stronger reporting of episodes in order to get a clearer picture.

"While the rupture rate of PIP was observed to be higher than expected in France, rates reported by other national authorities vary," it noted.

The WHO statement (www.who.int/csr/don/2012_01_17/en/index.html) links to health recommendations issued by 28 countries.

add to favorites email to friend print save as pdf

Related Stories

Australia: No higher risk from French implants

Jan 05, 2012

(AP) -- Australian health officials said they have found no evidence that potentially faulty French-made breast implants are at an increased risk of rupture in Australian women.

UK demands data on breast implant ruptures

Jan 04, 2012

(AP) -- Britain's health secretary has demanded that private U.K. clinics supply data by the end of the week on how many French-made PIP breast implants have ruptured in Britain.

Recommended for you

Hormonal therapy for transsexualism safe and effective

Jun 18, 2013

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

User comments

More news stories

Panic over MERS virus fades in Saudi

People in Saudi Arabia's Eastern Province have again started greeting friends with the traditional kiss on the cheek, and face masks in public are becoming rarer, as panic subsides over the outbreak of a deadly respiratory ...

French firemen test hypnosis to help victims

"Look me straight in the eye. Your mind is emptying, your body is relaxing," says the fireman, using the calming words of hypnosis to help a trauma victim—a technique being pioneered by fire crews in the eastern French ...